Pharmacovigilance

  • A quantitative benefit risk assessment of a vaccine
  • Full development and management of a risk management plan for a new vaccine in clinical development
  • Protocol development and feasibility assessment of maternal and neonatal outcomes following maternal immunisation
  • Rapid assessment of reactogenicity of a seasonal influenza vaccine


back

DRIVE: A call for tenders

Measuring brand-specific influenza vaccine effectiveness in EU/EEA: a call for tenders

Read more

New publication

P95 co-authored paper on Norovirus disease in Japan featured in PLoS Disease Forecasting & Surveillance ...
Read more

New publication

Paper of P95 co-authors has been published online




Read more
P-95